Metabolism: clinical and experimental最新文献

筛选
英文 中文
Sedentary behaviour and cardiometabolic health: Integrating the potential underlying molecular health aspects 久坐行为与心脏代谢健康:整合潜在的潜在分子健康方面
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-06 DOI: 10.1016/j.metabol.2025.156320
Wouter M.A. Franssen , Ine Nieste , Kenneth Verboven , Bert O. Eijnde
{"title":"Sedentary behaviour and cardiometabolic health: Integrating the potential underlying molecular health aspects","authors":"Wouter M.A. Franssen ,&nbsp;Ine Nieste ,&nbsp;Kenneth Verboven ,&nbsp;Bert O. Eijnde","doi":"10.1016/j.metabol.2025.156320","DOIUrl":"10.1016/j.metabol.2025.156320","url":null,"abstract":"<div><div>During the last decades, sedentary behaviour has been recognised as an interdependent risk factor for cardiometabolic health and premature mortality. Prolonged sedentary behaviour is associated with increased risks for chronic non-communicable diseases (NCDs) such as obesity, chronic respiratory diseases, type 2 diabetes mellitus, cardiovascular diseases and cancer due to disturbances in cardiometabolic health. However, despite the increased evidence supporting these associations, the underlying molecular mechanisms to the development of these NCDs remain largely unknown. In this review, we therefore discuss the existing evidence with regard to the potential underlying molecular mechanisms of sedentary behaviour-induced perturbations in cardiometabolic health. Here, various potential mechanisms related to carbohydrate metabolism, lipid metabolism, oxidative stress, inflammation and micro- and macro vascular function will be outlined. In addition, we summarise the current evidence on various strategies to interrupt sedentary behaviour and their effects on cardiometabolic health outcomes, including insulin sensitivity, blood lipid profiles, and cardiovascular health. Finally, we highlight key research gaps in the field of sedentary behaviour in relation to the underlying molecular mechanisms.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"170 ","pages":"Article 156320"},"PeriodicalIF":10.8,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144229905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ganoderic acid T, a novel activator of pyruvate carboxylase, exhibits potent anti-liver cancer activity 灵芝酸T是一种新型的丙酮酸羧化酶激活剂,具有很强的抗肝癌活性
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-04 DOI: 10.1016/j.metabol.2025.156321
Bo Lei , Mengjie Zhang , Xiangrui Shi , Na Feng , Jun Yin , Rui Dong , Chuanming Xie , Yinan Zhu , Jian-Jiang Zhong , Bing Ni
{"title":"Ganoderic acid T, a novel activator of pyruvate carboxylase, exhibits potent anti-liver cancer activity","authors":"Bo Lei ,&nbsp;Mengjie Zhang ,&nbsp;Xiangrui Shi ,&nbsp;Na Feng ,&nbsp;Jun Yin ,&nbsp;Rui Dong ,&nbsp;Chuanming Xie ,&nbsp;Yinan Zhu ,&nbsp;Jian-Jiang Zhong ,&nbsp;Bing Ni","doi":"10.1016/j.metabol.2025.156321","DOIUrl":"10.1016/j.metabol.2025.156321","url":null,"abstract":"<div><h3>Background</h3><div>Ganoderic acid T (GAT), a lanostane triterpenoid isolated from the methanol extract of <em>G. lucidum</em> mycelia, has demonstrated potent antitumor activity against various human cancer types. However, the specific molecular targets of GAT in cancer cells remain largely unknown. Therefore, this study systematically investigates these targets using the <em>in vitro</em> and <em>in vivo</em> hepatocellular carcinoma (HCC) model.</div></div><div><h3>Methods</h3><div>The anti-tumor activities of GAT were validated in HCC cells, xenograft tumor models in nude mice, and patient-derived organoid models. The specific molecular target of GAT was identified through targeted fishing techniques. Experimental approaches such as proteomics, metabolomics, biotin pull-down assays, molecular docking studies, molecular dynamics simulations, DARTS, CETSA, and biolayer interferometry (BLI) were employed to confirm the binding between GAT and its molecular target as well as elucidate the underlying mechanism.</div></div><div><h3>Results</h3><div>We have identified pyruvate carboxylase (PC) as a direct target of GAT. GAT, through its binding to the pocket composed of Arg453, Thr457, and Ile459 of PC, enhances the activity of PC, consequently disrupting the anaplerotic flux mediated by PC into the tricarboxylic acid (TCA) cycle. This disruption leads to impaired mitochondrial oxidative phosphorylation (OXPHOS) via the induction of reactive oxygen species (ROS)-mediated JNK/p38 MAPK signaling pathways, ultimately inhibiting HCC cell proliferation. Furthermore, molecular dynamics simulation suggests that GAT binds to and interacts with the biotin carboxylase (BC) domain of PC. This interaction potentially induces conformational changes in the protein structure of PC, leading to a tighter arrangement within the BC domain and stabilizing formation of a catalytically competent tetramer configuration for PC. The mutation of these key sites resulted in the destabilization of the BC domain and a reduction in the cytotoxic effect of GAT on HCC cells.</div></div><div><h3>Conclusion</h3><div>Overall, these findings demonstrate that GAT directly targets PC through an allosteric mechanism, providing valuable insights into the anti-HCC properties of GAT.</div></div>","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"170 ","pages":"Article 156321"},"PeriodicalIF":10.8,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144229907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation MASLD可能通过共享的代谢途径间接影响女性特异性癌症风险,而不是直接因果关系。
IF 11.9 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-04 DOI: 10.1016/j.metabol.2025.156322
Wenjie Li , Ruxue Lv
{"title":"MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation","authors":"Wenjie Li ,&nbsp;Ruxue Lv","doi":"10.1016/j.metabol.2025.156322","DOIUrl":"10.1016/j.metabol.2025.156322","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"171 ","pages":"Article 156322"},"PeriodicalIF":11.9,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144248766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of Established and Novel Non-invasive Tests, Including New Clinical and Metabolomics-Based Machine Learning Models, for Detecting MASH with Fibrosis Stages F2-F3: A First-in-Class Approach in the post-Resmetirom approval era 已建立的和新颖的无创测试的性能,包括新的临床和基于代谢组学的机器学习模型,用于检测F2-F3期纤维化的MASH: remetirom批准后时代的一流方法
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-01 DOI: 10.1016/j.metabol.2025.156206
Konstantinos Stefanakis , Geltrude Mingrone , Jacob George , Christos S. Mantzoros
{"title":"Performance of Established and Novel Non-invasive Tests, Including New Clinical and Metabolomics-Based Machine Learning Models, for Detecting MASH with Fibrosis Stages F2-F3: A First-in-Class Approach in the post-Resmetirom approval era","authors":"Konstantinos Stefanakis ,&nbsp;Geltrude Mingrone ,&nbsp;Jacob George ,&nbsp;Christos S. Mantzoros","doi":"10.1016/j.metabol.2025.156206","DOIUrl":"10.1016/j.metabol.2025.156206","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"168 ","pages":"Article 156206"},"PeriodicalIF":10.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144184384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inherited Stress Vulnerability Exacerbates Obesity-induced Metabolic Alterations Through Dysfunctional Adipose Tissue 遗传性应激易感性通过功能失调的脂肪组织加剧肥胖诱导的代谢改变
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-01 DOI: 10.1016/j.metabol.2025.156207
Saumya Kishor Mehta, Michaella Ben-Shachar, Albert Pinhasov, Tovit Rosenzweig
{"title":"Inherited Stress Vulnerability Exacerbates Obesity-induced Metabolic Alterations Through Dysfunctional Adipose Tissue","authors":"Saumya Kishor Mehta,&nbsp;Michaella Ben-Shachar,&nbsp;Albert Pinhasov,&nbsp;Tovit Rosenzweig","doi":"10.1016/j.metabol.2025.156207","DOIUrl":"10.1016/j.metabol.2025.156207","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"168 ","pages":"Article 156207"},"PeriodicalIF":10.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144184385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of Insulin Resistance, Type 2 Diabetes Mellitus, Obesity, and Colorectal Cancer Occurrence 胰岛素抵抗、2型糖尿病、肥胖与结直肠癌发生的相关性
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-01 DOI: 10.1016/j.metabol.2025.156198
Chong-Chi Chiu , Chao-Ming Hung
{"title":"Correlation of Insulin Resistance, Type 2 Diabetes Mellitus, Obesity, and Colorectal Cancer Occurrence","authors":"Chong-Chi Chiu ,&nbsp;Chao-Ming Hung","doi":"10.1016/j.metabol.2025.156198","DOIUrl":"10.1016/j.metabol.2025.156198","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"168 ","pages":"Article 156198"},"PeriodicalIF":10.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144184938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Biomarkers of Metabolic Inflammation: The Predictive Accuracy of Plasma Water T2 Exceeds That of High-Sensitivity C-Reactive Protein and Erythrocyte Sedimentation Rate 比较代谢性炎症的生物标志物:血浆水T2的预测准确性超过高敏c反应蛋白和红细胞沉降率
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-01 DOI: 10.1016/j.metabol.2025.156210
David P. Cistola , Alok K. Dwivedi
{"title":"Comparing Biomarkers of Metabolic Inflammation: The Predictive Accuracy of Plasma Water T2 Exceeds That of High-Sensitivity C-Reactive Protein and Erythrocyte Sedimentation Rate","authors":"David P. Cistola ,&nbsp;Alok K. Dwivedi","doi":"10.1016/j.metabol.2025.156210","DOIUrl":"10.1016/j.metabol.2025.156210","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"168 ","pages":"Article 156210"},"PeriodicalIF":10.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Targeting Inflammasome Signaling: Ginsana-115 as Prime Driver in Insulin Resistance/ cardiovascular Risk (CVD) in Prototypal Brain Disorder: Schizophrenia 探索靶向炎性小体信号:Ginsana-115作为原型脑疾病:精神分裂症中胰岛素抵抗/心血管风险(CVD)的主要驱动因素
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-01 DOI: 10.1016/j.metabol.2025.156216
Autumn Carriere, Simon S. Chiu, Michel Woodbury, Mariwan Husni, John Copen, Allison Foskett, Ed Lui, Robbie Campbell
{"title":"Exploring Targeting Inflammasome Signaling: Ginsana-115 as Prime Driver in Insulin Resistance/ cardiovascular Risk (CVD) in Prototypal Brain Disorder: Schizophrenia","authors":"Autumn Carriere,&nbsp;Simon S. Chiu,&nbsp;Michel Woodbury,&nbsp;Mariwan Husni,&nbsp;John Copen,&nbsp;Allison Foskett,&nbsp;Ed Lui,&nbsp;Robbie Campbell","doi":"10.1016/j.metabol.2025.156216","DOIUrl":"10.1016/j.metabol.2025.156216","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"168 ","pages":"Article 156216"},"PeriodicalIF":10.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Post-Bariatric Hypoglycemia (LUCIDITY) 一项3期、多中心、随机、双盲安慰剂对照研究评估阿维肽治疗减肥后低血糖的疗效和安全性
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-01 DOI: 10.1016/j.metabol.2025.156220
Ryan Miller , Marilyn Tan , Tracey McLaughlin , Mary Elizabeth Patti , Suzanne Bijl , Jennifer Hardy , Jorgji Kerthi , Jamie Timmons , Yuehui Wu , Zhengyu Yang , Lahar Mehta , Colleen Craig
{"title":"A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Post-Bariatric Hypoglycemia (LUCIDITY)","authors":"Ryan Miller ,&nbsp;Marilyn Tan ,&nbsp;Tracey McLaughlin ,&nbsp;Mary Elizabeth Patti ,&nbsp;Suzanne Bijl ,&nbsp;Jennifer Hardy ,&nbsp;Jorgji Kerthi ,&nbsp;Jamie Timmons ,&nbsp;Yuehui Wu ,&nbsp;Zhengyu Yang ,&nbsp;Lahar Mehta ,&nbsp;Colleen Craig","doi":"10.1016/j.metabol.2025.156220","DOIUrl":"10.1016/j.metabol.2025.156220","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"168 ","pages":"Article 156220"},"PeriodicalIF":10.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144184822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST 高皮质醇血症在难以控制的2型糖尿病和高血压患者中的患病率:来自CATALYST的结果
IF 10.8 1区 医学
Metabolism: clinical and experimental Pub Date : 2025-06-01 DOI: 10.1016/j.metabol.2025.156214
Yehuda Handelsman , Vanita R. Aroda , Timothy Bailey , Robert S. Busch , John B. Buse , Elena Christofides , Ralph A. DeFronzo , Bradley Eilerman , Vivian Fonseca , Adline Ghazi , Steven E. Kahn , Mark Kipnes , Dan Lender , Jonathan G. Ownby , Jean Park , Julio Rosenstock , Michael Shanik , Lance Sloan , Ron Swerdloff , Guillermo Umpierrez , Daniel Einhorn
{"title":"Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST","authors":"Yehuda Handelsman ,&nbsp;Vanita R. Aroda ,&nbsp;Timothy Bailey ,&nbsp;Robert S. Busch ,&nbsp;John B. Buse ,&nbsp;Elena Christofides ,&nbsp;Ralph A. DeFronzo ,&nbsp;Bradley Eilerman ,&nbsp;Vivian Fonseca ,&nbsp;Adline Ghazi ,&nbsp;Steven E. Kahn ,&nbsp;Mark Kipnes ,&nbsp;Dan Lender ,&nbsp;Jonathan G. Ownby ,&nbsp;Jean Park ,&nbsp;Julio Rosenstock ,&nbsp;Michael Shanik ,&nbsp;Lance Sloan ,&nbsp;Ron Swerdloff ,&nbsp;Guillermo Umpierrez ,&nbsp;Daniel Einhorn","doi":"10.1016/j.metabol.2025.156214","DOIUrl":"10.1016/j.metabol.2025.156214","url":null,"abstract":"","PeriodicalId":18694,"journal":{"name":"Metabolism: clinical and experimental","volume":"168 ","pages":"Article 156214"},"PeriodicalIF":10.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144184935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信